Blackstone and the Canada Pension Plan Investment Board have agreed the buyout of Genstar Capital’s Advarra, in a deal believed to value the business at about $5bn. Genstar and Linden Capital Partners will continue to hold stakes in Advarra, which provides services to ensure clinical trial participants safeguarding, compliance and optimize research performances. Never miss […]
The post Blackstone, CPPIB buy into Genstar Capital’s Advarra, valuation believed to be about $5bn first appeared on AltAssets Private Equity News.
